Fredun Pharmaceuticals Ltd Share Price

190.00

Open ()
Turnover (lac)
Prev. Close ()
Day's Vol.(shares)
Detailed Quote

Corporate Action

Period From
Period To
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 31-Jan-2020 - -
Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2020 ,inter alia, to consider and approve Pursuant to Regulation 29 of SEBI Listing Regulations, 2015; we wish to inform you that the 176th Meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, February 12, 2020 at 3:30 P.M. at the Registered Office of the Company interalia to discuss, consider and approve the Unaudited Financial Results of the Company for the Quarter and nine months ended December 31, 2019. The Board Meeting to be held on 12/02/2020 has been revised to 12/02/2020 In compliance to Regulation 47 of SEBI Listing Regulations, 2015; we enclose herewith the copies of the Notice of the ensuing Board Meeting of the Company scheduled to be held on Wednesday, February 12, 2020 at 3:30 P.M.; published in Business Standard & Mumbai Lakshadeep newspapers on February 1, 2020. (As Per BSE Announcement Dated on 01.02.2020)
Board Meeting - 26-Dec-2019 - -
In compliance to Regulation 30 of SEBI Listing Regulations, 2015; we wish to inform you that the Board of Directors of Fredun Pharmaceuticals Limited (hereinafter referred to as the Company), at their Meeting held on Thursday, December 26, 2019; had considered and approved the Cost Audit Report and discussed the other General Matters related to the Company.
Board Meeting - 01-Nov-2019 - -
Quarterly Results
Board Meeting - 31-Jul-2019 - -
Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2019 ,inter alia, to consider and approve Pursuant to Regulation 29 of SEBI Listing Regulations, 2015; we wish to inform you that the Meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, August 13, 2019 at 3:30 P.M. at the Registered Office of the Company interalia to discuss, consider and approve the Unaudited Financial Results of the Company for the Quarter ended June 30, 2019. We wish to inform you that the Board of Directors of Fredun Pharmaceuticals Limited (hereinafter referred to as the Company), at their Meeting held on Tuesday, August 13, 2019; had considered and approved the items of Business. (As Per BSE Announcement Dated On 13/08/2019) We enclose herewith the copies of the Newspaper cuttings of the Financials Results of the Company for the Quarter ended June 2019; as approved by the Board in its Meeting held on Tuesday, August 13, 2019; published in Business Standard & Mumbai Lakshadeep newspaper(s) on August 15, 2019. (As Per BSE Announcement Dated on 16/08/2019)
Board Meeting - 03-Jun-2019 - -
Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/06/2019 ,inter alia, to consider and approve We wish to inform you that the 172nd Meeting of the Board of Directors of the Company is scheduled to be held on Monday, June 10, 2019 at 3:00 P.M. at the Registered Office of the Company. The Board in its meeting had considered and approved the Dividend of Rs. 0.60/- per Rs.10/- Equity Share of the Company. In compliance to Regulation 33 ofSEBI Listing Regulations, 2015; we wish to inform you that the Board of Directors of Fredun Pharmaceuticals Limited (hereinafter referred to as the Company), at their Meeting held on Monday, June 10, 2019; had considered and approved the Financial Results for the year ended March 31, 2019. (As Per BSE Announcement Dated on 11.06.2019)
Board Meeting - 20-May-2019 - -
Fredun Pharmaceuticals Ltd has informed BSE that the Meeting of the Board of Directors of the Company is scheduled to be held on May 30, 2019, inter alia, for the following matters:1. To discuss, consider and approve the Audited Financial Results of the Company for the Quarter and Year endedMarch 31, 2019;2. To recommend Dividend if any, for the Financial Year ended March 2019 - subject to the approval of the Shareholders at the 32nd Annual General Meeting of the Company.Further, in continuation of Companys intimation dated April 04, 2019 and pursuant to Companys Code of Conduct forPrevention of insider Trading the trading window for dealing in the securities of the Company is closed from April 04, 2019 to June 01, 2019 (both days inclusive).The same has been circulated to the Directors, Key Managerial Personnel, Employees of the Company. Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2019 ,inter alia, to consider and approve Pursuant to Regulation 29 of SEBI Listing Regulations, 2015; we wish to inform you that the Meeting of the Board of Directors of the Company is scheduled to be held on Thursday, May 30, 2019 at 3:00 P.M. at the Registered Office of the Company to consider the matters as stated. We enclose herewith the copies of the Notice of the ensuing Board Meeting of the Company scheduled to be held on Thursday, May 30, 2019; published in Business Standard & Mumbai Lakshadeep newspaper on May 21, 2019 (As Per BSE Announcement Dated 21.05.2019) The Board Meeting to be held on 30/05/2019 Stands Cancelled. (As Per BSE Announcement Dated 30.05.2019)
Board Meeting - 09-Apr-2019 - -
In compliance to Regulation 30 of SEBI Listing Regulations, 2015; we wish to inform you that the Board of Directors of Fredun Pharmaceuticals Limited (hereinafter referred to as the Company), at their Meeting held on Tuesday, April 9, 2019; had considered and approved the Appointment of Mr. Fredun Medhora as the Chief Financial Officer (hereinafter referred to as the CFO) of the Company with immediate effect.